These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21757114)

  • 21. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure.
    Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Ochiai M
    ESC Heart Fail; 2018 Feb; 5(1):87-94. PubMed ID: 28967699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.
    Ter Maaten JM; Martens P; Damman K; Dickstein K; Ponikowski P; Lang CC; Ng LL; Anker SD; Samani NJ; Filippatos G; Cleland JG; Zannad F; Hillege HL; van Veldhuisen DJ; Metra M; Voors AA; Mullens W
    Clin Res Cardiol; 2020 Aug; 109(8):1048-1059. PubMed ID: 32002631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
    Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
    Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of serum potassium levels with mortality in chronic heart failure patients.
    Aldahl M; Jensen AC; Davidsen L; Eriksen MA; Møller Hansen S; Nielsen BJ; Krogager ML; Køber L; Torp-Pedersen C; Søgaard P
    Eur Heart J; 2017 Oct; 38(38):2890-2896. PubMed ID: 29019614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of serum uric acid change with mortality, renal function and diuretic dose administered in treatment of acute heart failure.
    Zhou HB; Xu TY; Liu SR; Bai YJ; Huang XF; Zhan Q; Zeng QC; Xu DL
    Nutr Metab Cardiovasc Dis; 2019 Apr; 29(4):351-359. PubMed ID: 30795993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.
    Masuyama T; Tsujino T; Origasa H; Yamamoto K; Akasaka T; Hirano Y; Ohte N; Daimon T; Nakatani S; Ito H
    Circ J; 2012; 76(4):833-42. PubMed ID: 22451450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated blood urea nitrogen-to-creatinine ratio increased the risk of hospitalization and all-cause death in patients with chronic heart failure.
    Lin HJ; Chao CL; Chien KL; Ho YL; Lee CM; Lin YH; Wu YW; Hsu RB; Chou NK; Wang SS; Chen CY; Chen MF
    Clin Res Cardiol; 2009 Aug; 98(8):487-92. PubMed ID: 19468780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure.
    Ter Maaten JM; Damman K; Hanberg JS; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Cotter G; Davison B; Cleland JG; Bloomfield DM; Hillege HL; van Veldhuisen DJ; Voors AA; Testani JM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27507112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry.
    Kapelios CJ; Laroche C; Crespo-Leiro MG; Anker SD; Coats AJS; Díaz-Molina B; Filippatos G; Lainscak M; Maggioni AP; McDonagh T; Mebazaa A; Metra M; Moura B; Mullens W; Piepoli MF; Rosano GMC; Ruschitzka F; Seferovic PM; Lund LH;
    Eur J Heart Fail; 2020 Aug; 22(8):1424-1437. PubMed ID: 32237110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of loop diuretic dose to mortality in advanced heart failure.
    Eshaghian S; Horwich TB; Fonarow GC
    Am J Cardiol; 2006 Jun; 97(12):1759-64. PubMed ID: 16765130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between changes in loop diuretic dose and outcomes in acute heart failure.
    Seko Y; Kato T; Morimoto T; Yaku H; Inuzuka Y; Tamaki Y; Ozasa N; Shiba M; Yamamoto E; Yoshikawa Y; Yamashita Y; Kitai T; Taniguchi R; Iguchi M; Nagao K; Kawai T; Komasa A; Nishikawa R; Kawase Y; Morinaga T; Toyofuku M; Furukawa Y; Ando K; Kadota K; Sato Y; Kuwahara K; Kimura T;
    ESC Heart Fail; 2023 Jun; 10(3):1757-1770. PubMed ID: 36858382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. eGFR and Outcomes in Patients with Acute Decompensated Heart Failure with or without Elevated BUN.
    Kajimoto K; Sato N; Takano T;
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):405-12. PubMed ID: 26769764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses.
    Balling L; Kistorp C; Schou M; Egstrup M; Gustafsson I; Goetze JP; Hildebrandt P; Gustafsson F
    J Card Fail; 2012 May; 18(5):351-8. PubMed ID: 22555263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
    Balsam P; Ozierański K; Tymińska A; Główczyńska R; Peller M; Fojt A; Cacko A; Sieradzki B; Bakuła E; Markulis M; Kowalik R; Huczek Z; Filipiak KJ; Opolski G; Grabowski M
    Trials; 2017 Jan; 18(1):36. PubMed ID: 28114980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION.
    Fudim M; O'Connor CM; Mulder H; Coles A; Bhatt AS; Ambrosy AP; Kraus WE; Piña IL; Whellan DJ; Mentz RJ
    Am Heart J; 2018 Nov; 205():133-141. PubMed ID: 30158057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between blood urea nitrogen-to-creatinine ratio at hospital admission and long-term mortality in patients with acute decompensated heart failure.
    Murata A; Kasai T; Matsue Y; Matsumoto H; Yatsu S; Kato T; Suda S; Hiki M; Takagi A; Daida H
    Heart Vessels; 2018 Aug; 33(8):877-885. PubMed ID: 29417223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
    Kiernan MS; Stevens SR; Tang WHW; Butler J; Anstrom KJ; Birati EY; Grodin JL; Gupta D; Margulies KB; LaRue S; Dávila-Román VG; Hernandez AF; de Las Fuentes L;
    J Card Fail; 2018 Jul; 24(7):428-438. PubMed ID: 29482026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood urea nitrogen variation upon admission and at discharge in patients with heart failure.
    Khoury J; Bahouth F; Stabholz Y; Elias A; Mashiach T; Aronson D; Azzam ZS
    ESC Heart Fail; 2019 Aug; 6(4):809-816. PubMed ID: 31199082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
    DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
    Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.